StonvexLoading…
StonvexStonvexStonvexCore line items from SYRE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $886.00K | $2.33M |
Operating Income | $-209.56M | $-208.57M | $-242.30M | $-84.78M |
Net Income | $-155.20M | $-208.02M | $-338.79M | $-83.81M |
EPS (Diluted) | Not available | Not available | $13.76 | $-24.86 |
Total Assets | $777.78M | $608.48M | $341.86M | $71.14M |
Total Liabilities | $62.55M | $90.68M | $73.29M | $20.84M |
Cash & Equivalents | $85.72M | $89.42M | $188.89M | $34.86M |
Free Cash Flow OCF − CapEx | Not available | $-157.41M | $-99.91M | $-80.18M |
Shares Outstanding | 78.19M | 60.26M | 36.06M | 2.61M |